Liver X receptor: From metabolism to cancer

Biochemical Journal

Volumn 459, Issue 2, 2014, Pages

  Venteclef, Nicolas ^a,b,c   Ferré, Pascal ^a,b,c  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cancer; Cholesterol; Inflammation; Liver X receptor; Metabolism; Oxysterol

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST;

BREAST CANCER; CANCER GROWTH; CELL MEMBRANE; CHOLESTEROL SYNTHESIS; CHROMATIN STRUCTURE; CLINICAL TRIAL (TOPIC); GLIOBLASTOMA; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MACROPHAGE ACTIVATION; METABOLISM; NEOPLASM; NONHUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER;

ANIMALS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC FACTORS; INFLAMMATION; INTERFERON-GAMMA; NEOPLASMS; ORPHAN NUCLEAR RECEPTORS; SIGNAL TRANSDUCTION; STEROLS;

EID: 84897509433     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20140211     Document Type: Note

References (15)

1. Dunn, G. P., Old, L. J. and Schreiber, R. D. (2004) The three Es of cancer immunoediting. Annu. Rev. Immunol. 22, 329-360 (Pubitemid 38680426)
2. Simons, K. and Ikonen, E. (2000) How cells handle cholesterol. Science 290, 1721-1726 (Pubitemid 32004797)
3. Ramirez, C. M., Rotllan, N., Vlassov, A. V., Davalos, A., Li, M., Goedeke, L., Aranda, J. F., Cirera-Salinas, D., Araldi, E., Salerno, A. et al. (2013) Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144. Circ. Res. 112, 1592-1601
4. Goldstein, J. L. and Brown, M. S. (1986) Atherosclerosis and its complications: contributions from the Association of American Physicians, 1886-1986. Trans. Assoc. Am. Physicians 99, ccxxxi-ccxlvii
5. Flamment, M., Hajduch, E., Ferre, P. and Foufelle, F. (2012) New insights into ER stress-induced insulin resistance. Trends Endocrinol. Metab. 23, 381-390
6. Calkin, A. C. and Tontonoz, P. (2012) Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13, 213-224
7. York, A. G. and Bensinger, S. J. (2013) Subverting sterols: rerouting an oxysterol-signaling pathway to promote tumor growth. J. Exp. Med. 210, 1653-1656
8. Poli, G., Biasi, F. and Leonarduzzi, G. (2013) Oxysterols in the pathogenesis of major chronic diseases. Redox Biol. 1, 125-130
9. Venteclef, N., Jakobsson, T., Steffensen, K. R. and Treuter, E. (2011) Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol. Metab. 22, 333-343
10. Venteclef, N., Jakobsson, T., Ehrlund, A., Damdimopoulos, A., Mikkonen, L., Ellis, E., Nilsson, L. M., Parini, P., Janne, O. A., Gustafsson, J. A. et al. (2010) GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRβ in the hepatic acute phase response. Genes Dev. 24, 381-395
11. Wang, Q., Ma, X., Chen, Y., Zhang, L., Jiang, M., Li, X., Xiang, R., Miao, R., Hajjar, D. P., Duan, Y. and Han, J. (2014) Identification of interferon-γ as a new molecular target of liver X receptor. Biochem. J. 459, 345-354
12. Zaidi, M. R. and Merlino, G. (2011) The two faces of interferon-γ in cancer. Clin. Cancer Res. 17, 6118-6124
13. Dunn, G. P., Old, L. J. and Schreiber, R. D. (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137-148 (Pubitemid 39094044)
14. Jakobsson, T., Treuter, E., Gustafsson, J. A. and Steffensen, K. R. (2012) Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol. Sci. 33, 394-404
15. Jakobsson, T., Venteclef, N., Toresson, G., Damdimopoulos, A. E., Ehrlund, A., Lou, X., Sanyal, S., Steffensen, K. R., Gustafsson, J. A. and Treuter, E. (2009) GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus. Mol. Cell 34, 510-518